Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma

被引:143
作者
Dong, Liang-qing [1 ,2 ]
Peng, Li-hua [3 ]
Ma, Li-jie [1 ,2 ]
Liu, Dong-bing [3 ,4 ]
Zhang, Shu [1 ,2 ]
Luo, Shu-zhen [3 ]
Rao, Jun-hua [3 ]
Zhu, Hong-wen [5 ,6 ]
Yang, Shuai-xi [1 ,2 ]
Xi, Shui-jun [1 ,2 ]
Chen, Min [7 ]
Xie, Fan-fan [3 ]
Li, Fu-qiang [3 ]
Li, Wen-hui [3 ]
Ye, Chen [3 ]
Lin, Li-ya [3 ]
Wang, Yu-jue [3 ]
Wang, Xiao-ying [1 ,2 ]
Gao, Da-ming [7 ]
Zhou, Hu [5 ,6 ]
Yang, Huan-ming [3 ,8 ]
Wane, Jian [3 ,8 ]
Zhu, Shi-da [3 ,9 ]
Wang, Xiang-dong [10 ]
Cao, Ya [11 ]
Zhou, Jian [1 ,2 ,12 ]
Fan, Jia [1 ,2 ,12 ,13 ]
Wu, Kui [3 ,4 ,9 ]
Gao, Qiang [1 ,2 ,12 ]
机构
[1] Fudan Univ, Dept Liver Surg & Transplantat, Liver Canc Inst, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai 200032, Peoples R China
[3] BGI Shenzhen, Shenzhen 518083, Peoples R China
[4] BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genom, Shenzhen Key Lab Genom, Shenzhen 518083, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
[7] Chinese Acad Sci, CAS Key Lab Syst Biol, Innovat Ctr Cell Signaling Network,Shanghai Inst, CAS Enter Excellence Mol Cell Sci,Inst Biochem &, Shanghai, Peoples R China
[8] James D Watson Inst Genome Sci, Hangzhou 310058, Peoples R China
[9] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark
[10] Fudan Univ, Shanghai Inst Clin Bioinformat, Zhongshan Hosp, Shanghai 200032, Peoples R China
[11] Cent South Univ, Key Lab Carcinogenesis & Invas, Chinese Minist Educ, Xiangya Hosp, Changsha 410078, Peoples R China
[12] Fudan Univ, Key Lab Med Epigenet & Metab, Inst Biomed Sci, Shanghai 200032, Peoples R China
[13] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Tumor heterogeneity; Tumor microenvironment; Immunoediting; Neoantigen; PD-1; BLOCKADE; CANCER; EXPRESSION; TISSUE; SENSITIVITY; PROGNOSIS;
D O I
10.1016/j.jhep.2019.12.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The presence of multifocal tumors, developed either from intrahepatic metastasis (IM) or multicentric occurrence (MO), is a distinct feature of hepatocellular carcinoma (HCC). Immunogenomic characterization of multifocal HCC is important for understanding immune escape in different lesions and developing immunotherapy. Methods: We combined whole-exome/transcriptome sequencing, multiplex immunostaining, immunopeptidomes, T cell receptor (TCR) sequencing and bioinformatic analyses of 47 tumors from 15 patients with HCC and multifocal lesions. Results: IM and MO demonstrated distinct clonal architecture, mutational spectrum and genetic susceptibility. The immune microenvironment also displayed spatiotemporal heterogeneity, such as less T cell and more M2 macrophage infiltration in IM and higher expression of inhibitory immune checkpoints in MO. Similar to mutational profiles, shared neoantigens and TCR repertoires among tumors from the same patients were abundant in IM but scarce in MO. Combining neoantigen prediction and immunopeptidomes identified T cell-specific neoepitopes and achieved a high verification rate in vitro. Immunoediting mainly occurred in MO but not IM, due to the relatively low immune infiltration. Loss of heterozygosity of human leukocyte antigen (HLA) alleles, identified in 17% of multifocal HCC, hampered the ability of major histocompatibility complex to present neoantigens, especially in IM. An integrated analysis of Immunoscore, immunoediting, TCR clonality and HLA loss of heterozygosity in each tumor could stratify patients into 2 groups based on whether they have a high or low risk of recurrence (p = 0.038). Conclusion: Our study comprehensively characterized the genetic structure, neoepitope landscape, T cell profile and immunoediting status that collectively shape tumor evolution and could be used to optimize personalized immunotherapies for multifocal HCC. Lay summary: Immunogenomic features of multifocal hepatocellular carcinoma (HCC) are important for understanding immune-escape mechanisms and developing more effective immunotherapy. Herein, comprehensive immunogenomic characterization showed that diverse genomic structures within multifocal HCC would leave footprints on the immune landscape. Only a few tumors were under the control of immunosurveillance, while others evaded the immune system through multiple mechanisms that led to poor prognosis. Our study revealed heterogeneous immunogenomic landscapes and immune-constrained tumor evolution, the understanding of which could be used to optimize personalized immunotherapies for multifocal HCC. (c) 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:896 / 908
页数:13
相关论文
共 44 条
  • [1] Gapped sequence alignment using artificial neural networks: application to the MHC class I system
    Andreatta, Massimo
    Nielsen, Morten
    [J]. BIOINFORMATICS, 2016, 32 (04) : 511 - 517
  • [2] Evolution of Metastases in Space and Time under Immune Selection
    Angelova, Mihaela
    Mlecnik, Bernhard
    Vasaturo, Angela
    Bindea, Gabriela
    Fredriksen, Tessa
    Lafontaine, Lucie
    Buttard, Benedicte
    Morgand, Erwan
    Bruni, Daniela
    Jouret-Mourin, Anne
    Hubert, Catherine
    Kartheuser, Alex
    Humblet, Yves
    Ceccarelli, Michele
    Syed, Najeeb
    Marincola, Francesco M.
    Bedognetti, Davide
    Van den Eynde, Marc
    Galon, Jerome
    [J]. CELL, 2018, 175 (03) : 751 - +
  • [3] Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
    Calis, Jorg J. A.
    Maybeno, Matt
    Greenbaum, Jason A.
    Weiskopf, Daniela
    De Silva, Aruna D.
    Sette, Alessandro
    Kesmir, Can
    Peters, Bjoern
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (10)
  • [4] Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
    Chowell, Diego
    Morris, Luc G. T.
    Grigg, Claud M.
    Weber, Jeffrey K.
    Samstein, Robert M.
    Makarov, Vladimir
    Kuo, Fengshen
    Kendall, Sviatoslav M.
    Requena, David
    Riaz, Nadeem
    Greenbaum, Benjamin
    Carroll, James
    Garon, Edward
    Hyman, David M.
    Zehir, Ahmet
    Solit, David
    Berger, Michael
    Zhou, Ruhong
    Rizvi, Naiyer A.
    Chan, Timothy A.
    [J]. SCIENCE, 2018, 359 (6375) : 582 - +
  • [5] Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
    El-Khoueiry, Anthony B.
    Sangro, Bruno
    Yau, Thomas
    Crocenzi, Todd S.
    Kudo, Masatoshi
    Hsu, Chiun
    Kim, Tae-You
    Choo, Su-Pin
    Trojan, Jorg
    Welling, Theodore H., III
    Meyer, Tim
    Kang, Yoon-Koo
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    dela Cruz, Christine
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    Dastani, Homa B.
    Melero, Ignacio
    [J]. LANCET, 2017, 389 (10088) : 2492 - 2502
  • [6] Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors
    Furuta, Mayuko
    Ueno, Masaki
    Fujimoto, Akihiro
    Hayami, Shinya
    Yasukawa, Satoru
    Kojima, Fumiyoshi
    Arihiro, Koji
    Kawakami, Yoshiiku
    Wardell, Christopher P.
    Shiraishi, Yuichi
    Tanaka, Hiroko
    Nakano, Kaoru
    Maejima, Kazuhiro
    Sasaki-Oku, Aya
    Tokunaga, Naoki
    Boroevich, Keith A.
    Abe, Tetsuo
    Aikata, Hiroshi
    Ohdan, Hideki
    Gotoh, Kunihito
    Kubo, Michiaki
    Tsunoda, Tatsuhiko
    Miyano, Satoru
    Chayama, Kazuaki
    Yamaue, Hiroki
    Nakagawa, Hidewaki
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 363 - 373
  • [7] Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
    Gao, Qiang
    Qiu, Shuang-Jian
    Fan, Jia
    Zhou, Jian
    Wang, Xiao-Ying
    Xiao, Yong-Sheng
    Xu, Yang
    Li, Yi-Wei
    Tang, Zhao-You
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2586 - 2593
  • [8] Multiple carcinogenesis contributes to the heterogeneity of HCC
    Gao, Qiang
    Wang, Xiao-Ying
    Zhou, Jian
    Fan, Jia
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (01) : 13 - 13
  • [9] Identifying specificity groups in the T cell receptor repertoire
    Glanville, Jacob
    Huang, Huang
    Nau, Allison
    Hatton, Olivia
    Wagar, Lisa E.
    Rubelt, Florian
    Ji, Xuhuai
    Han, Arnold
    Krams, Sheri M.
    Pettus, Christina
    Haas, Nikhil
    Arlehamn, Cecilia S. Lindestam
    Sette, Alessandro
    Boyd, Scott D.
    Scriba, Thomas J.
    Martinez, Olivia M.
    Davis, Mark M.
    [J]. NATURE, 2017, 547 (7661) : 94 - +
  • [10] PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
    Gordon, Sydney R.
    Aute, Roy L. M.
    Dulken, Ben W.
    Hutter, Gregor
    George, Benson M. .
    Ccracken, Melissa N. M.
    Gupta, Rohit
    Tsai, Jonathan M. .
    Sinha, Rahul
    Corey, Daniel
    Ring, Aaron M. .
    Connolly, Andrew J.
    Weissman, Irving L.
    [J]. NATURE, 2017, 545 (7655) : 495 - +